[ET Net News Agency, 11 August 2021] China Grand Pharmaceutical and Healthcare Holdings
Limited (00512) said the total profit attributable to owners of the company for the six
months ended 30 June 2021 amounted to HK$1,202.54 million, representing an increment of
67.4% as compared with the corresponding period in 2020. No dividend will be distributed.
It recorded revenue of HK$4,566.53 million, representing an increase of 40.3% as
compared to the corresponding period in 2020. (RC)